348 related articles for article (PubMed ID: 15072439)
1. Herbal modulation of P-glycoprotein.
Zhou S; Lim LY; Chowbay B
Drug Metab Rev; 2004 Feb; 36(1):57-104. PubMed ID: 15072439
[TBL] [Abstract][Full Text] [Related]
2. In vitro interaction of the HIV protease inhibitor ritonavir with herbal constituents: changes in P-gp and CYP3A4 activity.
Patel J; Buddha B; Dey S; Pal D; Mitra AK
Am J Ther; 2004; 11(4):262-77. PubMed ID: 15266218
[TBL] [Abstract][Full Text] [Related]
3. St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4.
Dürr D; Stieger B; Kullak-Ublick GA; Rentsch KM; Steinert HC; Meier PJ; Fattinger K
Clin Pharmacol Ther; 2000 Dec; 68(6):598-604. PubMed ID: 11180019
[TBL] [Abstract][Full Text] [Related]
4. Interactions of herbs with cytochrome P450.
Zhou S; Gao Y; Jiang W; Huang M; Xu A; Paxton JW
Drug Metab Rev; 2003 Feb; 35(1):35-98. PubMed ID: 12635815
[TBL] [Abstract][Full Text] [Related]
5. Review article: cytochrome P450 enzyme, and transport protein mediated herb-drug interactions in renal transplant patients: grapefruit juice, St John's Wort - and beyond!
Nowack R
Nephrology (Carlton); 2008 Jun; 13(4):337-47. PubMed ID: 18363644
[TBL] [Abstract][Full Text] [Related]
6. Quantitative characterization of direct P-glycoprotein inhibition by St John's wort constituents hypericin and hyperforin.
Wang EJ; Barecki-Roach M; Johnson WW
J Pharm Pharmacol; 2004 Jan; 56(1):123-8. PubMed ID: 14980009
[TBL] [Abstract][Full Text] [Related]
7. Disposition pathways and pharmacokinetics of herbal medicines in humans.
He SM; Li CG; Liu JP; Chan E; Duan W; Zhou SF
Curr Med Chem; 2010; 17(33):4072-113. PubMed ID: 20939821
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic interactions between herbal remedies and medicinal drugs.
Ioannides C
Xenobiotica; 2002 Jun; 32(6):451-78. PubMed ID: 12160480
[TBL] [Abstract][Full Text] [Related]
9. Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4.
Bhardwaj RK; Glaeser H; Becquemont L; Klotz U; Gupta SK; Fromm MF
J Pharmacol Exp Ther; 2002 Aug; 302(2):645-50. PubMed ID: 12130727
[TBL] [Abstract][Full Text] [Related]
10. Modulation of P-glycoprotein function by St John's wort extract and its major constituents.
Weber CC; Kressmann S; Fricker G; Müller WE
Pharmacopsychiatry; 2004 Nov; 37(6):292-8. PubMed ID: 15551196
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic interactions of drugs with St John's wort.
Zhou S; Chan E; Pan SQ; Huang M; Lee EJ
J Psychopharmacol; 2004 Jun; 18(2):262-76. PubMed ID: 15260917
[TBL] [Abstract][Full Text] [Related]
12. Hypericum perforatum: which constituents may induce intestinal MDR1 and CYP3A4 mRNA expression?
Gutmann H; Poller B; Büter KB; Pfrunder A; Schaffner W; Drewe J
Planta Med; 2006 Jun; 72(8):685-90. PubMed ID: 16755466
[TBL] [Abstract][Full Text] [Related]
13. MDR- and CYP3A4-mediated drug-herbal interactions.
Pal D; Mitra AK
Life Sci; 2006 Mar; 78(18):2131-45. PubMed ID: 16442130
[TBL] [Abstract][Full Text] [Related]
14. In vitro inhibition of CYP3A4 metabolism and P-glycoprotein-mediated transport by trade herbal products.
Hellum BH; Nilsen OG
Basic Clin Pharmacol Toxicol; 2008 May; 102(5):466-75. PubMed ID: 18331390
[TBL] [Abstract][Full Text] [Related]
15. Drug-herb interactions: eliminating toxicity with hard drug design.
Yang XX; Hu ZP; Duan W; Zhu YZ; Zhou SF
Curr Pharm Des; 2006; 12(35):4649-64. PubMed ID: 17168768
[TBL] [Abstract][Full Text] [Related]
16. Gauging the clinical significance of P-glycoprotein-mediated herb-drug interactions: comparative effects of St. John's wort, Echinacea, clarithromycin, and rifampin on digoxin pharmacokinetics.
Gurley BJ; Swain A; Williams DK; Barone G; Battu SK
Mol Nutr Food Res; 2008 Jul; 52(7):772-9. PubMed ID: 18214850
[TBL] [Abstract][Full Text] [Related]
17. Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein.
Sikic BI; Fisher GA; Lum BL; Halsey J; Beketic-Oreskovic L; Chen G
Cancer Chemother Pharmacol; 1997; 40 Suppl():S13-9. PubMed ID: 9272128
[TBL] [Abstract][Full Text] [Related]
18. The emerging recognition of herb-drug interactions with a focus on St. John's wort (Hypericum perforatum).
Markowitz JS; DeVane CL
Psychopharmacol Bull; 2001; 35(1):53-64. PubMed ID: 12397870
[TBL] [Abstract][Full Text] [Related]
19. Herb-drug interactions and mechanistic and clinical considerations.
Chen XW; Sneed KB; Pan SY; Cao C; Kanwar JR; Chew H; Zhou SF
Curr Drug Metab; 2012 Jun; 13(5):640-51. PubMed ID: 22292789
[TBL] [Abstract][Full Text] [Related]
20. Role of P-glycoprotein in drug disposition.
Tanigawara Y
Ther Drug Monit; 2000 Feb; 22(1):137-40. PubMed ID: 10688277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
